Effect of Highly Active Antiretroviral Therapy on Fundus Images and Retinal Microvessel Diameter in HIV/AIDS Patients

References

• Xie L-Y, Chen C, Kong W-J, Du K-F, Guo C-G, Wei W-B. A comparative study on retinal thickness of the macular region among AIDS patients with normal ocular fundus, HIV-related microvascular retinopathy patients, and cytomegalovirus retinitis patients. Medicine. 2019;98(26):e16073. doi:10.1097/MD.0000000000016073
   PubMed Web of Science ®Google Scholar
• Jabs DA, Van Natta ML, Trang G, et al. Association of systemic inflammation with retinal vascular caliber in patients with AIDS. Invest Ophthalmol Vis Sci. 2019;60(6):2218–2225. doi:10.1167/iovs.18-26070
   PubMed Web of Science ®Google Scholar
• Jabs DA, Van Natta ML, Pak JW, Danis RP, Hunt PW. Association of Retinal Vascular Caliber and Age-Related Macular Degeneration in Patients With the Acquired Immunodeficiency Syndrome. Invest Ophthalmol Vis Sci. 2018;59(2):904–908. doi:10.1167/iovs.17-23334
   PubMed Web of Science ®Google Scholar
• Chiotan C, Radu L, Serban R, Cornăcel C, Cioboată M, Anghelie A. Posterior segment ocular manifestations of HIV/AIDS patients. J Med Life. 2014;7(3):399. doi:10.1016/j.survophthal.2003.12.008
   PubMedGoogle Scholar
• Sun HY, Peng XY, Li D, Mao FF, You QS, Jonas JB. Cytomegalovirus retinitis in patients with AIDS before and after introduction of HAART in China. Eur J Ophthalmol. 2014;24(2):209–215. doi:10.5301/ejo.5000354
   PubMed Web of Science ®Google Scholar
• Silva B, Peixoto G, da Luz S, de Moraes S, Peres S. Adverse effects of chronic treatment with the Main subclasses of highly active antiretroviral therapy: a systematic review. HIV Med. 2019;20(7):429–438. doi:10.1111/hiv.12733
   PubMed Web of Science ®Google Scholar
• da Cunha J, Maselli LMF, Stern ACB, Spada C, Bydlowski SP. Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: old and new drugs. World j Virol. 2015;4(2):56. doi:10.5501/wjv.v4.i2.56
   PubMedGoogle Scholar
• Saydam O, Ozgen Saydam B, Adiyaman SC, et al. Risk factors for diabetic foot ulcers in metreleptin naïve patients with lipodystrophy. Clin Diabetes Endocrinol. 2021;7(1):1–10. doi:10.1186/s40842-021-00132-9
   PubMedGoogle Scholar
• Iwasaki Y, Yamamoto N, Kawaguchi T, et al. Human immunodeficiency virus-related retinal microangiopathy and systemic cytomegalovirus disease association. Jpn J Ophthalmol. 2013;57(4):372–378. doi:10.1007/s10384-013-0247-7
   PubMed Web of Science ®Google Scholar
• Gangaputra S, Kalyani PS, Fawzi AA, et al.; Studies of the Ocular Complications of AIDS Research Group. Retinal vessel caliber among people with acquired immunodeficiency syndrome: relationships with disease-associated factors and mortality. Am J Ophthalmol. 2012;153(3):434–444.e1. PMID: 22019225; PMCID: PMC3289046. doi:10.1016/j.ajo.2011.08.028
   PubMed Web of Science ®Google Scholar
• Pivetti-Pezzi P, Tamburi S, Accorinti M, et al. Immunological and viral markers of HIV infection and retinal microangiopathy. Eur J Ophthalmol. 1993;3(3):138–142. doi:10.1177/112067219300300306
   PubMedGoogle Scholar
• Gallo RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. science. 1984;224(4648):500–503. doi:10.1126/science.6200936
   PubMed Web of Science ®Google Scholar
• Dadgostar H, Holland GN, Huang X, et al. Hemorheologic abnormalities associated with HIV infection: in vivo assessment of retinal microvascular blood flow. Invest Ophthalmol Vis Sci. 2006;47(9):3933–3938. doi:10.1167/iovs.06-0138
   PubMed Web of Science ®Google Scholar
• Hanson DL, Chu SY, Farizo KM, Ward JW. Distribution of CD4+ T Lymphocytes at Diagnosis of Acquired Immunodeficiency Syndrome—Defining and Other Human Immunodeficiency Virus—Related Illnesses. Arch Intern Med. 1995;155(14):1537–1542. doi:10.1001/archinte.1995.00430140115012
   PubMedGoogle Scholar
• Chen C, Guo C-G, Meng L, et al. Comparative analysis of cytomegalovirus retinitis and microvascular retinopathy in patients with acquired immunodeficiency syndrome. Int J Ophthalmol. 2017;10(9):1396. doi:10.18240/ijo.2017.09.11
   PubMed Web of Science ®Google Scholar
• Ganta KK, Chaubey B. Mitochondrial dysfunctions in HIV infection and antiviral drug treatment. Expert Opin Drug Metab Toxicol. 2019;15(12):1043–1052. doi:10.1080/17425255.2019.1692814
   PubMed Web of Science ®Google Scholar
• Abah IO, Ncube N, Bradley HA, Agbaji OO, Kanki P. Antiretroviral Therapy-associated adverse drug reactions and their effects on virologic Failure-a retrospective cohort study in Nigeria. Curr HIV Res. 2018;16(6):436–446. doi:10.2174/1389450120666190214144609
   PubMed Web of Science ®Google Scholar
• Yang J, Chen J, Ji Y, et al. Lipid profile and renal safety of tenofovir disoproxil fumarate-based anti-retroviral therapy in HIV-infected Chinese patients. Int J Infect Dis. 2019;83:64–71. doi:10.1016/j.ijid.2019.03.034
   PubMed Web of Science ®Google Scholar
• Leyes P, Cofan M, González-Cordón A, et al. Increased cholesterol absorption rather than synthesis is involved in boosted protease inhibitor-associated hypercholesterolaemia. Aids. 2018;32(10):1309–1316. doi:10.1097/QAD.0000000000001837
   PubMed Web of Science ®Google Scholar
• Gibellini L, De Biasi S, Nasi M, et al. Different origin of adipogenic stem cells influences the response to antiretroviral drugs. Exp Cell Res. 2015;337(2):160–169. doi:10.1016/j.yexcr.2015.07.031
   PubMed Web of Science ®Google Scholar
• Ioannou GN, Bryson CL, Weiss NS, Boyko EJ. Associations between lipodystrophy or antiretroviral medications and cirrhosis in patients with HIV infection or HIV/HCV coinfection. Eur J Gastroenterol Hepatol. 2015;27(5):577–584. doi:10.1097/MEG.0000000000000290
   PubMed Web of Science ®Google Scholar
• Guaraldi G, Zona S, Orlando G, et al. Morphological and Metabolic Components of Lipodystrophy in Various Nevirapine-Based Highly Active Antiretroviral Therapy (HAART) Regimens. Clin Drug Investig. 2011;31(11):759–767. doi:10.1007/BF03256916
   PubMed Web of Science ®Google Scholar
• Dodson P, Galton D, Winder A. Retinal vascular abnormalities in the hyperlipidaemias. Trans Ophthalmol Soc U K. 1981;101(1):17–21.
   PubMedGoogle Scholar
• Gogri PY, Misra SL, Kothari RN, Bhandari AJ, Gidwani HV. Ophthalmic manifestations of HIV patients in a rural area of western Maharashtra, India. Int Scholarly ResNotices. 2014;2014:1–8. doi:10.1155/2014/347638
   Google Scholar
• Jiramongkolchai K, Liu TYA, Arevalo JF. Peripheral retinal neovascularization with vitreous hemorrhage in HIV retinopathy. Case Rep Ophthalmol. 2017;8(2):353–357. doi:10.1159/000477161
   PubMedGoogle Scholar
• Sahoo S. HIV-and AIDS-related ocular manifestations in Tanzanian patients. Malaysian j Med Sci. 2010;17(1):12.
   Google Scholar
• Golen JR, Eichenbaum D. Neovascularization of the optic disk and vitreous hemorrhage after immune recovery and treatment of cytomegalovirus retinitis in an HIV-positive patient. Retin Cases Brief Rep. 2013;7(4):395–398. doi:10.1097/ICB.0b013e318298bdb5
   PubMedGoogle Scholar
• Hemminki V, Kähönen M, Tuomisto MT, Turjanmaa V, Uusitalo H. Determination of retinal blood vessel diameters and arteriovenous ratios in systemic hypertension: comparison of different calculation formulae. Graefe’s Arch Clin Exp Ophthalmol. 2007;245(1):8–17. doi:10.1007/s00417-006-0358-7
   PubMed Web of Science ®Google Scholar